Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novartis evaluates SDZ-267-489 and analogues for increasing HDL cholesterol

Sep. 15, 1997

Potent GH secretagogues synthesized at Merck & Co.

Sep. 15, 1997

Kirin's TPO enters phase II in several Asian countries

Sep. 15, 1997

Cannabinoid receptor ligand shows synergistic hematopoietic effects in vitro

Sep. 12, 1997

Kampo medicine with hypolipidemic and antiatherosclerotic effects

Sep. 12, 1997

Focus on diabetes research in the U.S.

Sep. 12, 1997

Oxygent enhances oxygenation more effectively than blood in surgical patients

Sep. 11, 1997

SKB patents several series of vitronectin receptor antagonists

Sep. 11, 1997

Agents for enhancing erythropoiesis prepared at SmithKline Beecham

Sep. 10, 1997

PolyHeme blood substitute advances to phase III

Sep. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...